[ad_1] Head-to-Head Phase 3 Trial Compared to Pembrolizumab Initiated HONG KONG, Sept. 15, 2024 /PRNewswire/ — At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso released the Phase 2 clinical results of its […]
Tag: Inc.
Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated Development Timelines
[ad_1] Updated Phase 1 dose-escalation data from ARROS-1 and ALKOVE-1 clinical trials continue to support potential best-in-class profiles for zidesamtinib and NVL-655 Rapid enrollment in Phase 2 portions of the ARROS-1 and ALKOVE-1 clinical trials; […]
Books-A-Million Appoints Damian Doggett as Senior Vice President and Chief Accounting Officer
[ad_1] BIRMINGHAM, Ala., Sept. 13, 2024 /PRNewswire/ — Books-A-Million today announced the promotion of Damian Doggett to the position of Senior Vice President and Chief Accounting Officer. Terrance G. Finley, Chief Executive Officer of Books-A-Million, […]
JELD-WEN Completes Redemption of Senior Notes
[ad_1] CHARLOTTE, N.C., Sept. 13, 2024 /PRNewswire/ — JELD-WEN Holding, Inc. (NYSE: JELD) announced today that its subsidiary, JELD-WEN, Inc., completed the redemption of all $200 million aggregate principal amount of its outstanding 4.625% Senior […]
BLACK FRIDAY IS EVERY FRIDAY AT BIG LOTS NOW THROUGH DEC. 6
[ad_1] Popular Black Friday event will return for 2024 with special one-day deals every Friday Offers up to 50% off on single items or collections across product categories Black Fridays at Big Lots kick off […]
